Abstract:Abstract Introduction In the absence of reversible etiology, central sleep apnea (CSA) may be treated with positive airway pressure (CPAP or BPAP), adaptive servo-ventilation, or supplemental oxygen. In 2017, a transvenous phrenic nerve stimulator (PNS), the remedē SystemTM, was FDA-approved for moderate-to-severe CSA. Five-year outcomes data confirmed the device’s sustained efficacy, with improvements in symptoms, apnea-hypopnea index(AHI), and central apnea index(CAI). While the device effectively treats CSA, unrecognized upper airway obstruction may hinder clinical success. This case report describes a patient whose polysomnography (PSG) suggested candidacy for PNS; however, his airway collapsibility led to severe obstructive sleep apnea(OSA), unmasked after PNS implantation. Report of case(s) Our patient is a 74-year-old with longstanding severe CSA and chronic insomnia. He has a history of spasmodic dysphonia status post recurrent laryngeal nerve ablation. His unilateral vocal fold paralysis was followed by injection medialization for voice augmentation. He is also an asymptomatic carrier of myotonic dystrophy(MD), identified after his grandchild was diagnosed with MD. He presented to our institution for daytime sleepiness, disrupted sleep and snoring with complaints of PAP intolerance. PSG revealed an AHI4% of 49.1 events/hour with 0 obstructive apneas, 89 central apneas, and 53 unclassified hypopneas. Transthoracic echocardiogram was unremarkable. Pulmonary function tests were normal without evidence of neuromuscular weakness or extrathoracic obstruction. He underwent PNS implantation. Postoperatively, the patient continued endorsing unrefreshed sleep. His PNS titration study demonstrated prolonged flow limitation and an AHI4% of 35.2 events/hour with frequent obstructive events. He is now using a mandibular advancement device (MAD) with the PNS. Conclusion This case highlights the impact of upper airway collapsibility on PNS treatment response. Although our patient’s history may have indicated greater susceptibility to airway collapse, preoperative PSG did not reveal unequivocal OSA. However, frequent obstructive hypopneas were unmasked after PNS implantation. This patient’s upper airway collapse was underrepresented on PSG, and increased negative intrathoracic pressure during the PNS titration may have worsened the severity. Since differentiating central from obstructive hypopneas can be challenging, PNS may not be ideal for CSA patients with increased hypopnea burdens. If OSA emerges postoperatively, adjuncts like MAD, CPAP, or hypoglossal nerve stimulation may stabilize the upper airway. Support (if any)

Transvenous phrenic nerve stimulation is associated with normalization of nocturnal heart rate perturbations in patients with central sleep apnea

0618 Phrenic Nerve Stimulation for Central Sleep Apnea: A Single Institution Experience

Win ratio analysis of transvenous phrenic nerve stimulation to treat central sleep apnoea in heart failure

Interventional techniques to increase implantation success of transvenous phrenic nerve stimulation for central sleep apnea treatment

1173 Unmasking Severe OSA After Transvenous Phrenic Nerve Stimulation for Central Sleep Apnea

1186 Phrenic Nerve Stimulation to Improve Central Sleep Apnea and Quality of Life in Palliative Patients: A Case Report

1229 Dual Neurostimulator Therapy for CSA and OSA in an Elderly Gentleman with Native Pacemaker

Effect of Continuous Positive Airway Pressure Ventilation on Nocturnal ST-segment Changes in Patients with Sleep-Disordered Breathing

0280 Effect of Daily Transcutaneous Vagal Nerve Stimulation on Objective and Subjective Sleep Features in Healthy Adults

0459 Cardiovascular Endpoints for Obstructive Sleep Apnea with Twelfth Nerve Stimulation: Measures of Sleep-Related Function

1213 Vagal-nerve Stimulation Induced Refractory Central Sleep Apnea

[The Effects of Transcutaneous Electrical Stimulation During Sleep on Obstructive Sleep Apnea].

1163 Central Sleep Apnea: A Possible Rare Adverse Effect of Vagus Nerve Stimulation

Depicting and defining sleep disturbed breathing associated with vagal nerve stimulation

Hypoglossal nerve stimulation versus positive airway pressure therapy for obstructive sleep apnea

1168 Snoring Cessation in a Case of Vagal Nerve Stimulator Induced Obstructive Hypopnea

[Effect of transcutaneous auricular vagus nerve stimulation on nocturnal autonomic nervous function in primary insomnia patients]

Impact of optimized transcutaneous auricular vagus nerve stimulation on cardiac autonomic profile in healthy subjects and heart failure patients

Transcutaneous Vagus Nerve Stimulation Could Improve the Effective Rate on the Quality of Sleep in the Treatment of Primary Insomnia: A Randomized Control Trial

Effects of long-term transcutaneous auricular vagus nerve stimulation on circadian vagal activity in people with Prader-Willi Syndrome: A case-series

Ultrasound guided transcutaneous phrenic nerve stimulation in critically ill patients: a new method to evaluate diaphragmatic function